Skip to main content
Clinical Trials/NCT00404209
NCT00404209TerminatedPhase 3

Pressurized Perfluorocarbon Perfused 23 GA Vitrectomy in Complicated Diabetic Retinal Detachment

Asociación para Evitar la Ceguera en México2 sites in 1 country10 target enrollmentStarted: March 1, 2007Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Terminated
Sponsor
Enrollment
10
Locations
2
Primary Endpoint
Perfluorocarbon liquids consumption

Study Overview

Brief Summary

To investigate the feasibility and advantages of using pressurized perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting 23 GA vitrectomy using a dual, dynamic drive (3D)technology, in complicated retinal detachment surgeries.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Complicated retinal detachment with no more than 6months of evolution

Exclusion Criteria

  • Retinal detachments of more than 6 months of evolution No light perception

Outcomes

Primary Outcomes

Perfluorocarbon liquids consumption

Time Frame: two months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Asociación para Evitar la Ceguera en México
Sponsor Class
Other

Study Sites (2)

Loading locations...

Similar Trials

Pressurized PPV 23GA Vitrectomy in... | Clinical Trial